2023
DOI: 10.1016/j.ijpx.2023.100164
|View full text |Cite
|
Sign up to set email alerts
|

The applications of machine learning to predict the forming of chemically stable amorphous solid dispersions prepared by hot-melt extrusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…The use of machine learning in medicine for developing highly precise predictive models is on the rise [22][23][24]. To achieve this, a common approach involves utilizing the XGBoost algorithm, which is known for its high accuracy, along with the transparent Shapely Additive Explanations (SHAP) algorithm to determine crucial covariates and their predictive direction [25,26]. In our research, we expanded upon this approach by integrating dendrograms and heatmaps to visually summarize covariates based on their gain, cover, and frequency.…”
Section: Introductionmentioning
confidence: 99%
“…The use of machine learning in medicine for developing highly precise predictive models is on the rise [22][23][24]. To achieve this, a common approach involves utilizing the XGBoost algorithm, which is known for its high accuracy, along with the transparent Shapely Additive Explanations (SHAP) algorithm to determine crucial covariates and their predictive direction [25,26]. In our research, we expanded upon this approach by integrating dendrograms and heatmaps to visually summarize covariates based on their gain, cover, and frequency.…”
Section: Introductionmentioning
confidence: 99%
“…In early formulation development, 9- or 12-mm co-rotating twin-screw extruders (TSE) are frequently used for the production of amorphous solid dispersions (ASD) mainly resulting in a solubility enhancement of poorly water-soluble drugs, but still require batch sizes of about 20–30 g, which result in substantial amounts of drug substance and development costs, respectively ( Jiang et al, 2023 ; Zecevic and Wagner, 2013 ). The amount of protein-based drug candidates within early formulation development studies however, is often limited and thus small-scale HME is particularly relevant ( Dauer et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%